Pluribus Labs’s Graham Holdings Company GHC Stock Holding History

Pluribus Labs’s Portfolio GHC Stock Details GHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-481	Closed	-$303K	–	129
2021 Q4	$303K	Buy	+481	New	+$283K	0.32%	133

Other funds holding GHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

WCM

Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pluribus Labs's GHC Position: Q1 2022 in Review

Pluribus Labs sold out of Graham Holdings Company (GHC) in Q1 2022, closing a stake of 481 shares — an estimated $303K sold.

Pluribus Labs first reported a position in GHC in Q4 2021 and held it in 1 quarter. The position peaked at $303K in Q4 2021. 267 funds tracked by Wall St. Rank hold GHC as of Q1 2022.

Pluribus Labs reported no remaining Graham Holdings Company position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 481 Graham Holdings Company shares in Q1 2022, an estimated $303K.
Pluribus Labs first reported a position in Graham Holdings Company in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Graham Holdings Company position peaked at $303K in Q4 2021.
267 funds tracked by Wall St. Rank held Graham Holdings Company as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.